International study on inter-reader variability for circulating tumor cells in breast cancer

Michail Ignatiadis, Sabine Riethdorf, François Clement Bidard, Isabelle Vaucher, Mustapha Khazour, Françoise Rothé, Jessica Metallo, Ghizlane Rouas, Rachel E. Payne, Raoul C. Coombes, Ingrid Teufel, Ulrich Andergassen, Stella Apostolaki, Eleni Politaki, Dimitris Mavroudis, Silvia Bessi, Marta Pestrin, Angelo Di Leo, Michael Campion, Monica ReinholzEdith Perez, Martine Piccart, Elin Borgen, Bjorn Naume, Jose Jimenez, Claudia M. Aura, Laura Zorzino, Maria C. Cassatella, Maria T. Sandri, Bianca Mostert, Stefan Sleijfer, Jaco Kraan, Wolfgang Janni, Tanja Fehm, Brigitte Rack, Leon Terstappen, Madeline Repollet, Jean Yves Pierga, Craig Miller, Christos Sotiriou, Stefan Michiels, Klaus Pantel

Research output: Contribution to journalArticle

35 Scopus citations

Abstract

Introduction: Circulating tumor cells (CTCs) have been studied in breast cancer with the CellSearch® system. Given the low CTC counts in non-metastatic breast cancer, it is important to evaluate the inter-reader agreement.Methods: CellSearch® images (N = 272) of either CTCs or white blood cells or artifacts from 109 non-metastatic (M0) and 22 metastatic (M1) breast cancer patients from reported studies were sent to 22 readers from 15 academic laboratories and 8 readers from two Veridex laboratories. Each image was scored as No CTC vs CTC HER2- vs CTC HER2+. The 8 Veridex readers were summarized to a Veridex Consensus (VC) to compare each academic reader using % agreement and kappa (κ) statistics. Agreement was compared according to disease stage and CTC counts using the Wilcoxon signed rank test.Results: For CTC definition (No CTC vs CTC), the median agreement between academic readers and VC was 92% (range 69 to 97%) with a median κ of 0.83 (range 0.37 to 0.93). Lower agreement was observed in images from M0 (median 91%, range 70 to 96%) compared to M1 (median 98%, range 64 to 100%) patients (P < 0.001) and from M0 and <3CTCs (median 87%, range 66 to 95%) compared to M0 and ≥3CTCs samples (median 95%, range 77 to 99%), (P < 0.001). For CTC HER2 expression (HER2- vs HER2+), the median agreement was 87% (range 51 to 95%) with a median κ of 0.74 (range 0.25 to 0.90).Conclusions: The inter-reader agreement for CTC definition was high. Reduced agreement was observed in M0 patients with low CTC counts. Continuous training and independent image review are required.

Original languageEnglish (US)
Article numberR43
JournalBreast Cancer Research
Volume16
Issue number2
DOIs
StatePublished - Apr 23 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'International study on inter-reader variability for circulating tumor cells in breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Ignatiadis, M., Riethdorf, S., Bidard, F. C., Vaucher, I., Khazour, M., Rothé, F., Metallo, J., Rouas, G., Payne, R. E., Coombes, R. C., Teufel, I., Andergassen, U., Apostolaki, S., Politaki, E., Mavroudis, D., Bessi, S., Pestrin, M., Di Leo, A., Campion, M., ... Pantel, K. (2014). International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Research, 16(2), [R43]. https://doi.org/10.1186/bcr3647